Banque Cantonale Vaudoise’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.42M | Buy |
6,501
+835
| +15% | +$183K | 0.06% | 302 |
|
2025
Q1 | $1.27M | Buy |
+5,666
| New | +$1.27M | 0.06% | 309 |
|
2024
Q3 | $813K | Sell |
2,707
-5,066
| -65% | -$1.52M | 0.03% | 343 |
|
2024
Q2 | $2.56M | Buy |
7,773
+1,691
| +28% | +$557K | 0.1% | 195 |
|
2024
Q1 | $2.41M | Sell |
6,082
-26
| -0.4% | -$10.3K | 0.09% | 219 |
|
2023
Q4 | $2.15M | Buy |
6,108
+2,574
| +73% | +$906K | 0.09% | 220 |
|
2023
Q3 | $1.33M | Sell |
3,534
-667
| -16% | -$250K | 0.07% | 253 |
|
2023
Q2 | $1.61M | Buy |
4,201
+2,301
| +121% | +$880K | 0.08% | 230 |
|
2023
Q1 | $659K | Hold |
1,900
| – | – | 0.03% | 393 |
|
2022
Q4 | $447K | Hold |
1,900
| – | – | 0.02% | 472 |
|
2022
Q3 | $467K | Hold |
1,900
| – | – | 0.03% | 493 |
|
2022
Q2 | $575K | Sell |
1,900
-600
| -24% | -$182K | 0.03% | 459 |
|
2022
Q1 | $1.03M | Hold |
2,500
| – | – | 0.04% | 382 |
|
2021
Q4 | $1.17M | Sell |
2,500
-3,681
| -60% | -$1.73M | 0.05% | 379 |
|
2021
Q3 | $2.62M | Buy |
6,181
+1,738
| +39% | +$738K | 0.11% | 177 |
|
2021
Q2 | $1.6M | Buy |
4,443
+1,643
| +59% | +$590K | 0.07% | 291 |
|
2021
Q1 | $789K | Sell |
2,800
-1,500
| -35% | -$423K | 0.04% | 427 |
|
2020
Q4 | $1.22M | Hold |
4,300
| – | – | 0.07% | 255 |
|
2020
Q3 | $1.18M | Sell |
4,300
-200
| -4% | -$55K | 0.08% | 228 |
|
2020
Q2 | $1.02M | Sell |
4,500
-6,500
| -59% | -$1.48M | 0.07% | 267 |
|
2020
Q1 | $1.67M | Buy |
11,000
+3,200
| +41% | +$487K | 0.14% | 151 |
|
2019
Q4 | $1.17M | Buy |
+7,800
| New | +$1.17M | 0.08% | 263 |
|